Glucagon (1 - 29), bovine, human, porcine CAS NO.16941-32-5
Glucagon (1 - 29), derived from bovine, human, and porcine sources, is a peptide hormone with significant physiological implications. Its unique molecular structure, characterized by the formula C₁₅₃H₂₂₅N₄₃O₄₉S and a molecular weight of 3482.78, enables it to play a crucial role in glucose metabolism regulation.
About this product
Product information from the supplier.
TECHNICAL SPECIFICATIONS
| Item | Specification |
|---|---|
| Product Name | Glucagon (1 - 29), bovine, human, porcine |
| CAS NO. | 16941 - 32 - 5 |
| Appearance | White to off-white lyophilized powder |
| Molecular Formula | C215H357N71O67S |
| Molecular Weight | 3482.78g/mol |
| Purity (RP-HPLC) | ≥98% |
| Solubility | Soluble in water |
| Endotoxin | ≤1.0 EU/mg |
| Biological Activity | Glucagon (1 - 29) exhibits the characteristic biological activity of glucagon, which includes stimulating glycogenolysis (the breakdown of glycogen to glucose) and gluconeogenesis (the synthesis of glucose from non - carbohydrate sources) in the liver, thereby increasing blood glucose levels. In in vitro assays using liver cell lines or isolated hepatocytes |
| Storage Conditions | tore at - 20°C in a dry environment, protected from light. Avoid repeated freeze - thaw cycles to maintain its stability and biological activity. |
| Stock Location | Stock in USA |
| MOQ | 1g |
1.MECHANISM OF ACTION
Glucagon (1 - 29) primarily acts on the liver cells. It binds to specific glucagon receptors on the surface of these cells, triggering a cascade of intracellular signaling pathways. This activation stimulates glycogenolysis, the breakdown of glycogen into glucose, releasing it into the bloodstream. Additionally, it promotes gluconeogenesis, the synthesis of glucose from non - carbohydrate precursors such as amino acids and glycerol. These processes collectively lead to an elevation in blood glucose levels.
- Research Applications: Widely used in biological and medical research laboratories to study glucose metabolism disorders, such as diabetes. It helps researchers understand the normal physiological regulation of blood sugar levels and the pathophysiology of diabetes - related conditions.
- Potential Therapeutic Exploration: Although not yet a mainstream therapeutic agent, Glucagon (1 - 29) shows promise in the exploration of novel treatments for hypoglycemic disorders. It can be used to counteract severe hypoglycemia in certain clinical scenarios where rapid elevation of blood glucose is required.
2.PRODUCT INDICATIONS
3.CLINICAL EFFICACY OF PRODUCT
4.DELIVERY & SHIPPING
We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods
Main Method: International Air Freight
We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.




